Dou Liu
Impact in
- Cell Biology top 1%
- Microtubule and mitosis dynamics
- Molecular Biology top 2%
- DNA Repair Mechanisms
- PI3K/AKT/mTOR signaling in cancer
- Ubiquitin and proteasome pathways
- Fungal and yeast genetics research
- Genomics and Chromatin Dynamics
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 8
- DNA Repair Mechanisms 5
- Ubiquitin and proteasome pathways 4
- Oncology 11
- Drug Transport and Resistance Mechanisms 7
- Co-authors
- Stephen J. Elledge (7 shared papers)Bing Su (13 shared papers)Jun Qin (3 shared papers)Estela Jacinto (2 shared papers)Valeria Facchinetti (2 shared papers)Sung Yun Jung (2 shared papers)Qiaojia Huang (1 shared paper)Andrew Wakeham (1 shared paper)
- Journals
- Pharmaceutics (5 papers)European Journal of Pharmaceutical Sciences (3 papers)Cell (3 papers)Carbohydrate Polymers (2 papers)Immunity (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dou Liu
54 papers receiving 4.7k citations
Dou Liu's Hit Papers
Peers
Comparison fields: 5 of 136
- Cell Biology 933
- Molecular Biology 3.5k
- Oncology 1.1k
- Cancer Research 537
- Aging 51
Countries citing papers authored by Dou Liu
This map shows the geographic impact of Dou Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dou Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dou Liu more than expected).
Fields of papers citing papers by Dou Liu
This network shows the impact of papers produced by Dou Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dou Liu. The network helps show where Dou Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dou Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity Hit paper breakdown → | 2006 | 1184 |
| 2 | DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2 Hit paper breakdown → | 2000 | 1077 |
| 3 | 1999 | 450 | |
| 4 | 2003 | 340 | |
| 5 | 2001 | 210 | |
| 6 | 2012 | 136 | |
| 7 | 2021 | 132 | |
| 8 | 2001 | 111 | |
| 9 | 2012 | 93 | |
| 10 | 2015 | 67 | |
| 11 | 2003 | 65 | |
| 12 | 2010 | 63 | |
| 13 | 2011 | 62 | |
| 14 | 2015 | 52 | |
| 15 | 2021 | 47 | |
| 16 | 2016 | 44 | |
| 17 | 2020 | 44 | |
| 18 | Multi-Level microTESLA: A Broadcast Authentication System for Distributed Sensor Networks | 2003 | 39 |
| 19 | 2018 | 37 | |
| 20 | 2012 | 33 |
About Dou Liu
Dou Liu is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 57 papers that have together received 4.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (8 papers), Drug Transport and Resistance Mechanisms (7 papers), DNA Repair Mechanisms (5 papers), Microtubule and mitosis dynamics (5 papers), Ubiquitin and proteasome pathways (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Cell Biology (933 citations), Molecular Biology (3.5k citations), Oncology (1.1k citations), Cancer Research (537 citations) and Aging (51 citations). Dou Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Stephen J. Elledge, Bing Su, Jun Qin, Estela Jacinto, Valeria Facchinetti, Sung Yun Jung, Qiaojia Huang, Andrew Wakeham, Atsushi Hirao and Hiroki Yoshida. Their work appears in journals such as Pharmaceutics, European Journal of Pharmaceutical Sciences, Cell, Carbohydrate Polymers and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.